OBJECTIVE: To highlight emerging evidence for clinical and biological links between autism/pervasive developmental disorder (PDD) and schizophrenia, with particular attention to childhood-onset schizophrenia (COS). METHOD: Clinical, demographic, and brain developmental data from the National Institute of Mental Health (and other) COS studies and selected family, imaging, and genetic data from studies of autism, PDD, and schizophrenia were reviewed. RESULTS: In the two large studies that have examined this systematically, COS is preceded by and comorbid with PDD in 30% to 50% of cases. Epidemiological and family studies find association between the disorders. Both disorders have evidence of accelerated trajectories of anatomic brain development at ages near disorder onset. A growing number of risk genes and/or rare small chromosomal variants (microdeletions or duplications) are shared by schizophrenia and autism. CONCLUSIONS: Biological risk does not closely follow DSM phenotypes, and core neurobiological processes are likely common for subsets of these two heterogeneous clinical groups. Long-term prospective follow-up of autistic populations and greater diagnostic distinction between schizophrenia spectrum and autism spectrum disorders in adult relatives are needed.
OBJECTIVE: To highlight emerging evidence for clinical and biological links between autism/pervasive developmental disorder (PDD) and schizophrenia, with particular attention to childhood-onset schizophrenia (COS). METHOD: Clinical, demographic, and brain developmental data from the National Institute of Mental Health (and other) COS studies and selected family, imaging, and genetic data from studies of autism, PDD, and schizophrenia were reviewed. RESULTS: In the two large studies that have examined this systematically, COS is preceded by and comorbid with PDD in 30% to 50% of cases. Epidemiological and family studies find association between the disorders. Both disorders have evidence of accelerated trajectories of anatomic brain development at ages near disorder onset. A growing number of risk genes and/or rare small chromosomal variants (microdeletions or duplications) are shared by schizophrenia and autism. CONCLUSIONS: Biological risk does not closely follow DSM phenotypes, and core neurobiological processes are likely common for subsets of these two heterogeneous clinical groups. Long-term prospective follow-up of autistic populations and greater diagnostic distinction between schizophrenia spectrum and autism spectrum disorders in adult relatives are needed.
Authors: Nader Ghebranious; Philip F Giampietro; Frederic P Wesbrook; Shereif H Rezkalla Journal: Am J Med Genet A Date: 2007-07-01 Impact factor: 2.802
Authors: R E Straub; B K Lipska; M F Egan; T E Goldberg; J H Callicott; M B Mayhew; R K Vakkalanka; B S Kolachana; J E Kleinman; D R Weinberger Journal: Mol Psychiatry Date: 2007-05-01 Impact factor: 15.992
Authors: Ravinesh A Kumar; Samer KaraMohamed; Jyotsna Sudi; Donald F Conrad; Camille Brune; Judith A Badner; T Conrad Gilliam; Norma J Nowak; Edwin H Cook; William B Dobyns; Susan L Christian Journal: Hum Mol Genet Date: 2007-12-21 Impact factor: 6.150
Authors: Maricela Alarcón; Brett S Abrahams; Jennifer L Stone; Jacqueline A Duvall; Julia V Perederiy; Jamee M Bomar; Jonathan Sebat; Michael Wigler; Christa L Martin; David H Ledbetter; Stanley F Nelson; Rita M Cantor; Daniel H Geschwind Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Dan E Arking; David J Cutler; Camille W Brune; Tanya M Teslovich; Kristen West; Morna Ikeda; Alexis Rea; Moltu Guy; Shin Lin; Edwin H Cook; Aravinda Chakravarti Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta Journal: Neurotoxicology Date: 2015-12-22 Impact factor: 4.294
Authors: Mart L J M Eussen; Esther I de Bruin; Arthur R Van Gool; Anneke Louwerse; Jan van der Ende; Fop Verheij; Frank C Verhulst; Kirstin Greaves-Lord Journal: Eur Child Adolesc Psychiatry Date: 2014-05-10 Impact factor: 4.785